Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Phage choice, isolation, and preparation for phage therapy.

Gill JJ, Hyman P.

Curr Pharm Biotechnol. 2010 Jan;11(1):2-14. Review.

PMID:
20214604
2.

Designing phage therapeutics.

Goodridge LD.

Curr Pharm Biotechnol. 2010 Jan;11(1):15-27.

PMID:
20214605
3.

Phage therapy in clinical practice: treatment of human infections.

Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST.

Curr Pharm Biotechnol. 2010 Jan;11(1):69-86. Review.

PMID:
20214609
4.

Phage therapy pharmacology.

Abedon ST, Thomas-Abedon C.

Curr Pharm Biotechnol. 2010 Jan;11(1):28-47. Review.

PMID:
20214606
5.

The 'nuts and bolts' of phage therapy.

Abedon ST.

Curr Pharm Biotechnol. 2010 Jan;11(1):1. No abstract available.

PMID:
20214603
6.

Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations.

Hagens S, Loessner MJ.

Curr Pharm Biotechnol. 2010 Jan;11(1):58-68. Review.

PMID:
20214608
7.

Bacteriophages: an appraisal of their role in the treatment of bacterial infections.

Hanlon GW.

Int J Antimicrob Agents. 2007 Aug;30(2):118-28. Epub 2007 Jun 12. Review.

PMID:
17566713
8.

Phage therapy for plant disease control.

Balogh B, Jones JB, Iriarte FB, Momol MT.

Curr Pharm Biotechnol. 2010 Jan;11(1):48-57. Review.

PMID:
20214607
9.

Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.

Viertel TM, Ritter K, Horz HP.

J Antimicrob Chemother. 2014 Sep;69(9):2326-36. doi: 10.1093/jac/dku173. Epub 2014 May 28. Review.

PMID:
24872344
10.

Phage cocktails and the future of phage therapy.

Chan BK, Abedon ST, Loc-Carrillo C.

Future Microbiol. 2013 Jun;8(6):769-83. doi: 10.2217/fmb.13.47. Review.

11.

[Bacteriophages as antibacterial agents].

Shasha SM, Sharon N, Inbar M.

Harefuah. 2004 Feb;143(2):121-5, 166. Review. Hebrew.

PMID:
15143702
12.

Kinetics of phage-mediated biocontrol of bacteria.

Abedon ST.

Foodborne Pathog Dis. 2009 Sep;6(7):807-15. doi: 10.1089/fpd.2008.0242. Review.

PMID:
19459758
13.

Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.

Ryan EM, Gorman SP, Donnelly RF, Gilmore BF.

J Pharm Pharmacol. 2011 Oct;63(10):1253-64. doi: 10.1111/j.2042-7158.2011.01324.x. Epub 2011 Jul 6. Review.

PMID:
21899540
14.

Bacteriophages as therapeutic agents.

Sulakvelidze A, Morris JG Jr.

Ann Med. 2001 Nov;33(8):507-9.

PMID:
11730156
15.

Phage therapy.

Housby JN, Mann NH.

Drug Discov Today. 2009 Jun;14(11-12):536-40. doi: 10.1016/j.drudis.2009.03.006. Epub 2009 Mar 11. Review.

PMID:
19508915
16.

Quality and safety requirements for sustainable phage therapy products.

Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G.

Pharm Res. 2015 Jul;32(7):2173-9. doi: 10.1007/s11095-014-1617-7. Epub 2015 Jan 14.

17.

Bacteriophage therapy in children: facts and prospects.

Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.

Med Sci Monit. 2008 Aug;14(8):RA126-32. Review.

PMID:
18668009
18.

Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.

Chanishvili N.

Adv Virus Res. 2012;83:3-40. doi: 10.1016/B978-0-12-394438-2.00001-3. Review.

PMID:
22748807
19.

[New perspectives of the phage therapy].

Eyer L, Pantůcek R, Růzicková V, Doskar J.

Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):231-5. Review. Czech.

PMID:
18320502
20.

Phage therapy: past history and future prospects.

Carlton RM.

Arch Immunol Ther Exp (Warsz). 1999;47(5):267-74. Review.

PMID:
10604231

Supplemental Content

Support Center